TerrAscend Inkomsten in het verleden
Verleden criteriumcontroles 0/6
TerrAscend is de winst gegroeid met een gemiddeld jaarlijks percentage van 21%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 27.1%. De inkomsten zijn gegroeid met een gemiddelde van 6.7% per jaar.
Belangrijke informatie
21.04%
Groei van de winst
27.91%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 23.06% |
| Inkomstengroei | 6.71% |
| Rendement op eigen vermogen | -32.49% |
| Nettomarge | -12.04% |
| Laatste winstupdate | 30 Jun 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • Aug 10
TSND: Disciplined M&A And Capital Moves Will Support Future Upside
Analysts have adjusted their fair value estimate for TerrAscend to CA$2.25 from CA$2.01 as they revisit assumptions on revenue growth, profit margins and future P/E expectations. What's in the News for TerrAscend TerrAscend executives reiterated on the second quarter 2026 results call that the company is seeking acquisitions that are accretive and focused on markets where it already has scale and infrastructure, with an emphasis on using existing operations to pursue higher vertical revenue and operating leverage.
Narratiefupdate • Jul 02
TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside
Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.Narratiefupdate • Jun 18
TSND: Expanding M&A Pipeline And New Leadership Will Support Future Profitability
Analysts have nudged their fair value price target for TerrAscend to CA$2.01. This reflects updated assumptions for discount rate, revenue growth, profit margin and future P/E that slightly adjust how they frame the stock’s risk and earnings potential.Narratiefupdate • Jun 03
TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability
Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.Narratiefupdate • May 07
TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).Narratiefupdate • Apr 18
TSND: New CFO Hire And Share Buyback Will Support Future Upside
Analysts have modestly adjusted their price target on TerrAscend, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Together, these factors refine their view of what the shares could be worth in CA$ terms.Narratiefupdate • Apr 04
TSND: New Brand Partnership And Share Buyback Will Support Future Upside
Analysts have nudged their TerrAscend price target modestly higher to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland, covering premium flower and high potency vape products under its exclusive partnership with the brand (Key Developments).Narratiefupdate • Mar 20
TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability
Analysts have slightly adjusted their CA$ price target on TerrAscend, citing updated assumptions for revenue growth, profit margins, and a modest change in the expected future P/E multiple. What's in the News TerrAscend completed a share buyback tranche between October 1, 2025 and December 31, 2025, repurchasing 75,000 shares for $0.03m, equal to 0.02% of shares under the program first announced on August 20, 2025 (Key Developments).Narratiefupdate • Mar 04
TSND: Expanded New Jersey Footprint Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from about CA$1.98, citing updated assumptions that include a modestly adjusted discount rate, changes to revenue growth and profit margin expectations, and a higher future P/E estimate. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey.Narratiefupdate • Feb 18
TSND: Union Chill Expansion Will Support Future Retail Scale And Margins
Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).Analyse-artikel • Feb 12
More Unpleasant Surprises Could Be In Store For TerrAscend Corp.'s (TSE:TSND) Shares After Tumbling 27%
TerrAscend Corp. ( TSE:TSND ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Narratiefupdate • Feb 04
TSND: Union Chill Deal Will Drive Future Retail And Margin Upside
Analysts have trimmed their price target on TerrAscend to about US$1.25 from roughly US$1.50, citing reduced revenue growth expectations and a lower future P/E multiple, partly offset by higher projected profit margins. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County, New Jersey, and bringing its retail footprint in the state to four dispensaries (Key Developments).Narratiefupdate • Jan 21
TSND: Expanded Retail Footprint And Licensing Will Support Future Profitability
Analysts have modestly revised their price target on TerrAscend, citing slightly firmer profit margin expectations and a small adjustment to revenue trends and future P/E assumptions. Together, these factors support a refined fair value estimate without a material change in the overall valuation level.Narratiefupdate • Jan 06
TSND: Expanded Mid Atlantic Footprint And Licensing Will Support Higher Profitability
Analysts have nudged their price target on TerrAscend toward about $2.00, reflecting updated views that incorporate higher projected profit margins, a lower assumed future P/E multiple near 43, and adjusted revenue expectations. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County and bringing TerrAscend's New Jersey retail footprint to four dispensaries (Key Developments).Narratiefupdate • Dec 15
TSND: Licensing Expansion Into Mid Atlantic Markets Will Drive Stronger Profitability
Analysts have raised their price target on TerrAscend by approximately $2.25 to about $1.98 per share. They cited expectations for stronger profit margins and a more reasonable future earnings multiple, even as they moderate revenue growth assumptions and apply a slightly higher discount rate.Analyse-artikel • Dec 14
TerrAscend Corp.'s (TSE:TSND) Shares Climb 123% But Its Business Is Yet to Catch Up
TerrAscend Corp. ( TSE:TSND ) shares have had a really impressive month, gaining 123% after a shaky period beforehand...Analyse-artikel • Nov 09
Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75
TerrAscend Corp. ( TSE:TSND ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...Analyse-artikel • Oct 30
TerrAscend Corp.'s (TSE:TSND) 27% Share Price Plunge Could Signal Some Risk
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 27% over the previous 30 days, handing back...Analyse-artikel • Jun 11
Some TerrAscend Corp. (TSE:TSND) Shareholders Look For Exit As Shares Take 34% Pounding
Unfortunately for some shareholders, the TerrAscend Corp. ( TSE:TSND ) share price has dived 34% in the last thirty...Analyse-artikel • Apr 27
TerrAscend Corp. (TSE:TSND) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
The TerrAscend Corp. ( TSE:TSND ) share price has fared very poorly over the last month, falling by a substantial 30...
Nieuw narratief • Apr 02
ERP Implementation And Ohio Expansion Will Improve Operational Efficiency
Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration.Analyse-artikel • Mar 05
With A 29% Price Drop For TerrAscend Corp. (TSE:TSND) You'll Still Get What You Pay For
To the annoyance of some shareholders, TerrAscend Corp. ( TSE:TSND ) shares are down a considerable 29% in the last...Analyse-artikel • Jan 03
These 4 Measures Indicate That TerrAscend (TSE:TSND) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyse-artikel • Sep 03
Is TerrAscend (TSE:TSND) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyse-artikel • Apr 25
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analyse-artikel • Mar 10
What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 25% over the previous 30 days, handing back...Analyse-artikel • Jan 24
Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
TerrAscend Corp. ( TSE:TSND ) shareholders would be excited to see that the share price has had a great month, posting...Analyse-artikel • Dec 25
Is TerrAscend (TSE:TSND) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyse-artikel • Aug 13
TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Opbrengsten en kosten
Opbrengsten en kosten
Hoe TerrAscend geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 26 | 264 | -32 | 88 | 0 |
| 31 Mar 26 | 262 | -28 | 87 | 0 |
| 31 Dec 25 | 261 | -29 | 86 | 0 |
| 30 Sep 25 | 299 | -71 | 107 | 0 |
| 30 Jun 25 | 261 | -25 | 89 | 0 |
| 31 Mar 25 | 263 | -26 | 91 | 0 |
| 31 Dec 24 | 268 | -28 | 91 | 0 |
| 30 Sep 24 | 288 | -81 | 96 | 0 |
| 30 Jun 24 | 312 | -74 | 101 | 0 |
| 31 Mar 24 | 317 | -81 | 109 | 0 |
| 31 Dec 23 | 251 | -36 | 84 | 0 |
| 30 Sep 23 | 300 | -50 | 121 | 0 |
| 30 Jun 23 | 277 | -342 | 119 | 0 |
| 31 Mar 23 | 269 | -311 | 122 | 0 |
| 31 Dec 22 | 248 | -304 | 116 | 0 |
| 30 Sep 22 | 212 | -298 | 94 | 0 |
| 30 Jun 22 | 195 | 59 | 88 | 0 |
| 31 Mar 22 | 189 | 13 | 76 | 0 |
| 31 Dec 21 | 194 | 13 | 75 | 0 |
| 30 Sep 21 | 211 | -96 | 88 | 0 |
| 30 Jun 21 | 200 | -165 | 80 | 0 |
| 31 Mar 21 | 175 | -144 | 73 | 0 |
| 31 Dec 20 | 132 | -125 | 61 | 0 |
| 30 Sep 20 | 118 | -159 | 54 | 1 |
| 30 Jun 20 | 99 | -156 | 55 | 1 |
| 31 Mar 20 | 75 | -155 | 49 | 1 |
| 31 Dec 19 | 64 | -161 | 46 | 1 |
| 30 Sep 19 | 48 | -44 | 41 | 0 |
| 30 Jun 19 | 30 | -33 | 32 | 0 |
| 31 Mar 19 | 16 | -23 | 25 | 0 |
| 31 Dec 18 | 5 | -16 | 17 | 0 |
| 30 Sep 18 | 1 | -9 | 12 | 0 |
| 30 Jun 18 | 0 | -8 | 7 | 0 |
| 31 Mar 18 | 0 | -7 | 6 | 0 |
| 31 Dec 17 | 0 | -5 | 5 | 0 |
| 30 Sep 17 | 0 | -5 | 4 | 0 |
| 30 Jun 17 | 0 | -4 | 3 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
Kwaliteitswinsten: TSND is momenteel verliesgevend.
Groeiende winstmarge: TSND is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: TSND is verlieslatend, maar heeft de verliezen de afgelopen 5 jaar met een snelheid van 21% per jaar verminderd.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van TSND over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: TSND is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Pharmaceuticals industrie ( 225.5% ).
Rendement op eigen vermogen
Hoge ROE: TSND heeft een negatief Return on Equity ( -32.49% ), omdat het momenteel verliesgevend is.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/09 12:42 |
| Aandelenkoers aan het einde van de dag | 2026/09/09 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
TerrAscend Corp. wordt gevolgd door 9 analisten. 3 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Matt Bottomley | Canaccord Genuity |
| Shaan Mir | Canaccord Genuity |